Teva Pharmaceutical Industries Limited vs Johnson & Johnson
TEVA vs JNJ — side-by-side comparison from reported financials. TEVA leads 2, JNJ leads 8 of 10 comparable metrics.
Teva Pharmaceutical Industries Limited
TEVA · Healthcare
$41.21+4.99%Strained
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
| Metric | TEVA | JNJ |
|---|---|---|
| Price | $41.21 | $261.79 |
| Market cap | $48.1B | $631B |
| Revenue (TTM) | $17.3B | $97.9B |
| Revenue growth | +5.0% | +5.6% |
| Net margin | 4.1% | 21.5% |
| Free cash flow | $1.35B | $22.2B |
| Net cash (debt) | $1.74B | ($27.8B) |
| 1-year price return | +105.6% | +37.0% |
| P/E | 63.2 | 29.9 |
| P/E vs own history (cheap-side %) | 0% | 16% |
| Dividend yield | — | 2.00% |
| Return on equity | 9% | 26% |
| Altman Z-score | 0.63 | — |
| CV checks passed | 7 of 10 | 10 of 10 |
| Employees | 32,842 | 140,800 |
Full résumé-style profiles: TEVA CV · JNJ CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.